Document is current
Any future updates will be listed below
-
Authors
Xu, Chungui
Lin, Weihao
Zhang, Qi
Ma, Yarui
Wang, Xue
Guo, Ai
Zhu, Guiling
Zhou, Zhendiao
Song, Weiwei
Zhao, Ziyi
Jiao, Yuchen
Wang, Xiaobing
Du, Chunxia
-
Funding
Funding for this research was provided by:
the National Key R&D Program of China (2021YFC2500900, 2021YFC2501004)
the National Natural Science Foundation Fund (82372696, 82172988)
the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2021-I2M-1-014, 2021-I2M-1-067)
Non-profit central research institute fund of Chinese Academy of Medical Sciences (2022-RC310-08)
the Beijing Hope Run Special Fund of Cancer Foundation of China (LC2022R01)
- License Information
-
More Information
Article History
Received: 24 June 2024
Accepted: 22 October 2024
First Online: 5 November 2024
Declarations
:
: The animal study protocol was approved by the Institutional Review Board (or Ethics Committee) of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC2023A090). All authors had access to the study data, reviewed and approved the final manuscript.
: All authors agreed to the publication of this article.
: The authors declare no competing interests.
